glp1Tariff appliesAnnex III — Jul 31 2026

Ozempic Tariff Rate & July 31, 2026 Deadline

Ozempic (Semaglutide) — manufactured by Novo Nordisk in Denmark. Treats type 2 diabetes (also used off-label for weight loss). Typical US retail $968 per month.

Tariff breakdown

Applicable rate: 100% (Annex III)
Effective date: 2026-07-31 (98 days away)
Manufacturer: Novo Nordisk
Country of origin: Denmark
Annex III?: Yes
Current monthly retail: $968

Projected monthly retail, by pass-through scenario

Scenario	Pass-through	New monthly retail	Annual increase
Conservative	30%	$1,258	+$3,485
Likely	50%	$1,452	+$5,808
Worst case	100%	$1,936	+$11,616

Scenarios based on historical brand-pharma cost-shock pass-through. Not a forecast.

HTS classification

HTS 3004.90.9299

Semaglutide in pen injector, packaged for retail sale, falls under HTS 3004.90 (medicaments not elsewhere specified, put up for retail sale). Source country: Denmark.

Source: USITC Harmonized Tariff Schedule, 2026 Revision 2 — hts.usitc.gov

Alternatives: generics, biosimilars & US-made options

Mounjaro (tirzepatide, Eli Lilly)

us made

Manufactured in Indiana and North Carolina — tariff-exempt. Different molecule but same therapeutic class (incretin for type 2 diabetes).

Trulicity (dulaglutide, Eli Lilly)

us made

US-manufactured GLP-1 alternative, tariff-exempt.

Rybelsus (oral semaglutide)

therapeutic alternative

Same molecule in oral form; also Novo Nordisk and subject to the same tariff.

Always consult your prescriber before switching medications. Biosimilars and generics are not interchangeable in every state without physician approval.

FAQ: Ozempic and the 2026 tariff

Will my Ozempic prescription cost more after July 31, 2026?

Likely yes. Ozempic is manufactured in Denmark and is not exempt. Our conservative-case scenario assumes 30% pass-through (retail +$290/month), our likely-case 50% (+$484/month), and worst-case full pass-through (+$968/month).

Can I switch to a generic version of Semaglutide?

No FDA-approved generic of Semaglutide is widely available in the US as of 2026 Q2. Biosimilars or therapeutic alternatives (listed above) are the practical substitutes.

Is Ozempic on the Medicare negotiated-price list?

Ozempic is not among the first-round Medicare-negotiated drugs effective 2026. Check CMS announcements for subsequent negotiation rounds.

Importing pharmaceuticals commercially?

This page covers consumer drug pricing. For business imports (including finished-dose pharmaceuticals), use the full US import tariff calculator with HTS classification and Section 301/232/122 breakdown.

Disclaimer: Informational estimates based on public list prices, the April 2, 2026 Proclamation text, and USITC HTS data. Not medical, legal, or financial advice.

Talk to your doctor, pharmacist, and insurer about your specific medication.